The Australian medical sector is excited with the emergence of retatrutide, a novel dual GIP and GLP-1 medication showing impressive results in early trials for managing obesity. This medication offers a https://auresortwear.com/2026/06/10/retatrutide-australia-my-deep-dive-into-weight-loss-treatments/